SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:umu-192961"
 

Search: id:"swepub:oai:DiVA.org:umu-192961" > Structural Modifica...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Islam, Koushikul,1985-Umeå universitet,Institutionen för klinisk mikrobiologi (author)

Structural Modifications and Biological Evaluations of Rift Valley Fever Virus Inhibitors Identified from Chemical Library Screening

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-02-16
  • American Chemical Society (ACS),2022
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-192961
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-192961URI
  • https://doi.org/10.1021/acsomega.1c06513DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The Rift Valley fever virus (RVFV) is an emerging high-priority pathogen endemic in Africa with pandemic potential. There is no specific treatment or approved antiviral drugs for the RVFV. We previously developed a cell-based high-throughput assay to screen small molecules targeting the RVFV and identified a potential effective antiviral compound (1-N-(2-(biphenyl-4-yloxy)ethyl)propane-1,3-diamine) as a lead compound. Here, we investigated how structural modifications of the lead compound affected the biological properties and the antiviral effect against the RVFV. We found that the length of the 2-(3-aminopropylamino)ethyl chain of the compound was important for the compound to retain its antiviral activity. The antiviral activity was similar when the 2-(3-aminopropylamino)ethyl chain was replaced with a butyl piperazine chain. However, we could improve the cytotoxicity profile of the lead compound by changing the phenyl piperazine linker from the para-position (compound 9a) to the meta-position (compound 13a). Results from time-of-addition studies suggested that compound 13a might be active during virus post-entry and/or the replication phase of the virus life cycle and seemed to affect the K+ channel. The modifications improved the properties of our lead compound, and our data suggest that 13a is a promising candidate to evaluate further as a therapeutic agent for RVFV infection.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Carlsson, MarcusUmeå universitet,Kemiska institutionen(Swepub:umu)mascan97 (author)
  • Enquist, Per-AndersUmeå universitet,Kemiska institutionen(Swepub:umu)peen0006 (author)
  • Qian, WeixingUmeå universitet,Kemiska institutionen(Swepub:umu)weqi0002 (author)
  • Marttila, MarkoUmeå universitet,Institutionen för klinisk mikrobiologi(Swepub:umu)maomaa00 (author)
  • Strand, Mårten,1982-Umeå universitet,Institutionen för klinisk mikrobiologi(Swepub:umu)mansnd02 (author)
  • Ahlm, Clas,1956-Umeå universitet,Institutionen för klinisk mikrobiologi(Swepub:umu)clah0001 (author)
  • Evander, MagnusUmeå universitet,Institutionen för klinisk mikrobiologi(Swepub:umu)maev0001 (author)
  • Umeå universitetInstitutionen för klinisk mikrobiologi (creator_code:org_t)

Related titles

  • In:ACS Omega: American Chemical Society (ACS)7:8, s. 6854-68682470-1343

Internet link

Find in a library

  • ACS Omega (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view